CVB homepage

The Parasol Med Tech left atrial appendage closure (LAAO) system uses gel to completely fill and seal the LAA while a temporary shield prevents the gel from embolizing during delivery.

The new device from Chicago-based Parasol Med Tech uses gel to seal the left atrial appendage. It leaves no metal hardware behind.

Aubrey Shick, a digital health policy expert on regulatory and product strategy with Launch and Logic LLC, and a former Senior Digital Health Advisor at the U.S. Food and Drug Administration (FDA), explains how the Trump administration's push for faster artificial intelligence (AI) adoption in healthcare is being done and challenges for the FDA amid government downsizing.

Expertise and commitment of FDA reviewers remain in place, but the agency’s ability to communicate openly with industry has become a significant concern.

Andrew Einstein, MD, PhD, FACC, MASNC, MSCCT, FSCMR, incoming 2027 president of the American Society of Nuclear Cardiology (ASNC), professor of medicine in radiology, and director of nuclear cardiology, cardiac CT and cardiac MRI at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, discusses the potential and limitations of using coronary CT angiography (CCTA) as a screening modality. He also discusses the role of opportunistic imaging.

Andrew Einstein, MD, PhD, spoke to Cardiovascular Business about the potential benefits and limitations of using coronary CT angiography as a screening modality.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Heartflow filed the lawsuit after Elucid received FDA clearance for its new AI-enabled FFR-CT software. Elucid, meanwhile, is standing behind its technology and plans on responding through the appropriate legal channels.

Sudhir Srivastava, MD, conducting a live long-distance cardiac telesurgery at the EACTS 2026 annual meting, utilizing the SSi MantrAsana tele-surgeon console. The system enables 3D imaging to help the surgeon better understand the spacial relations of the anatomy where they are working.

The procedure, believed to be the first of its kind, was performed at the 2026 European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, Spain.

the words "FDA recall" on a board

Medtronic is recalling more than 700 OmniaSecure defibrillation leads, urging customers to quarantine and return them. The FDA has ruled this is a Class II recall. No adverse events have been reported.

Innovation at work

Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.

Sponsored by Philips Healthcare